文献速递胸部肿瘤放疗放疗物理与技术

四维计算机断层扫描通气图像引导的肺功能回避放疗:一项单臂前瞻性先导临床试验

Four-Dimensional Computed Tomography Ventilation Image-Guided Lung Functional Avoidance Radiation Therapy: A Single-Arm Prospective Pilot Clinical Trial.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2022-11-24

这项前瞻性先导试验评估了四维CT通气图像引导的肺功能回避放疗的安全性与可行性,纳入34例非小细胞肺癌患者,33例可评估。功能回避计划较标准计划显著降低了肺剂量-功能指标(P<.01),且未牺牲靶区覆盖或危及器官约束依从性,常规分割放疗组≥3级肺炎和食管炎发生率分别为4.2%和12.5%,立体定向体部放疗组无≥3级不良事件。

要点

  • 四维CT通气图像引导的功能回避计划较标准计划显著降低肺剂量-功能指标(P<.01)。
  • 常规分割放疗组≥3级肺炎发生率4.2%,≥3级食管炎发生率12.5%。
  • 立体定向体部放疗组无患者发生≥3级不良事件。

核心结论

  • 四维CT通气图像引导的肺功能回避放疗可安全实施,并显著降低通气肺区域的剂量。

研究设计与样本

  • 前瞻性单臂先导临床试验,2015年5月至2019年11月纳入34例非小细胞肺癌患者,33例可评估(常规分割放疗24例,立体定向体部放疗9例)。
  • 中位随访14.7个月。

主要发现

  • 常规分割放疗组≥3级肺炎发生率为4.2%(95%CI 0.1%-21.1%),≥3级食管炎发生率为12.5%(95%CI 2.7%-32.4%)。
  • 立体定向体部放疗组无患者发生≥3级不良事件。
  • 与标准计划相比,功能回避计划显著降低肺剂量-功能指标(P<.01),且未牺牲靶区覆盖或标准危及器官约束的依从性。

关键数值与推荐

  • 主要终点为安全性,定义为治疗后≤12个月内发生的≥3级不良事件率。
  • 常规分割放疗方案的安全性阈值:≥3级肺炎发生率<13%且≥3级食管炎发生率<21%。
  • 立体定向体部放疗方案的安全性阈值:任何≥3级不良事件发生率<28%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The primary objective of this prospective pilot trial was to assess the safety and feasibility of lung functional avoidance radiation therapy (RT) with 4-dimensional (4D) computed tomography (CT) ventilation imaging. METHODS AND MATERIALS: Patients with primary lung cancer or metastatic disease to the lungs to receive conventionally fractionated RT (CFRT) or stereotactic body RT (SBRT) were eligible. Standard-of-care 4D-CT scans were used to generate ventilation images through image processing/analysis. Each patient required a standard intensity modulated RT plan and ventilation image guided functional avoidance plan. The primary endpoint was the safety of functional avoidance RT, defined as the rate of grade ≥3 adverse events (AEs) that occurred ≤12 months after treatment. Protocol treatment was considered safe if the rates of grade ≥3 pneumonitis and esophagitis were <13% and <21%, respectively for CFRT, and if the rate of any grade ≥3 AEs was <28% for SBRT. Feasibility of functional avoidance RT was assessed by comparison of dose metrics between the 2 plans using the Wilcoxon signed-rank test. RESULTS: Between May 2015 and November 2019, 34 patients with non-small cell lung cancer were enrolled, and 33 patients were evaluable (n = 24 for CFRT; n = 9 for SBRT). Median follow-up was 14.7 months. For CFRT, the rates of grade ≥3 pneumonitis and esophagitis were 4.2% (95% confidence interval, 0.1%-21.1%) and 12.5% (2.7%-32.4%). For SBRT, no patients developed grade ≥3 AEs. Compared with the standard plans, the functional avoidance plans significantly (P < .01) reduced the lung dose-function metrics without compromising target coverage or adherence to standard organs at risk constraints. CONCLUSIONS: This study, representing one of the first prospective investigations on lung functional avoidance RT, demonstrated that the 4D-CT ventilation image guided functional avoidance RT that significantly reduced dose to ventilated lung regions could be safely administered, adding to the growing body of evidence for its clinical utility.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Yamamoto T, Kabus S, Bal M, et al. Four-Dimensional Computed Tomography Ventilation Image-Guided Lung Functional Avoidance Radiation Therapy: A Single-Arm Prospective Pilot Clinical Trial. Int J Radiat Oncol Biol Phys. 2022. PMID: 36427643. doi:10.1016/j.ijrobp.2022.11.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。